Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Hedetoft

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Medical Research|November 10, 2023
Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study)Julie Vinkel, Leonor Rib, Alfonso Buil, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 19, 2021
Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infectionMorten Hedetoft, Peter Østrup Jensen, Claus Moser, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Effect of immunoglobulin G on cytokine response in necrotising soft-tissue infection: A post hoc analysisMorten Hedetoft, Martin B Madsen, Anders Perner, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 14, 2021
Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infectionMorten Hedetoft, Claus Moser, Peter Østrup Jensen, et al.
Diving and Hyperbaric Medicine|June 24, 2016
Decompression illness treated in Denmark 1999-2013Christian Svendsen Juhl, Morten Hedetoft, Daniel Bidstrup, et al.
Journal of Innate Immunity|December 14, 2021
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue InfectionMorten Hedetoft, Martin Bruun Madsen, Cecilie Bo Hansen, et al.
BMC Infectious Diseases|October 10, 2021
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infectionMorten Hedetoft, Marco Bo Hansen, Martin Bruun Madsen, et al.
Scientific Reports|March 27, 2019
SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort studyPeter Polzik, Olav Grøndal, Juliette Tavenier, et al.
Diving and Hyperbaric Medicine|March 19, 2020
Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatmentMorten Hedetoft, Niels V Olsen, Isabel G Smidt-Nielsen, et al.
Diving and Hyperbaric Medicine|June 21, 2025
Core outcome set for research in necrotising soft tissue infection patients: an international, multidisciplinary, modified Delphi consensus studyBridget Devaney, Jonathan Pc Wackett, Nicola Ma, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Medical Research|November 10, 2023
Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study)Julie Vinkel, Leonor Rib, Alfonso Buil, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|May 19, 2021
Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infectionMorten Hedetoft, Peter Østrup Jensen, Claus Moser, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Effect of immunoglobulin G on cytokine response in necrotising soft-tissue infection: A post hoc analysisMorten Hedetoft, Martin B Madsen, Anders Perner, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 14, 2021
Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infectionMorten Hedetoft, Claus Moser, Peter Østrup Jensen, et al.
Diving and Hyperbaric Medicine|June 24, 2016
Decompression illness treated in Denmark 1999-2013Christian Svendsen Juhl, Morten Hedetoft, Daniel Bidstrup, et al.
Journal of Innate Immunity|December 14, 2021
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue InfectionMorten Hedetoft, Martin Bruun Madsen, Cecilie Bo Hansen, et al.
BMC Infectious Diseases|October 10, 2021
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infectionMorten Hedetoft, Marco Bo Hansen, Martin Bruun Madsen, et al.
Scientific Reports|March 27, 2019
SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort studyPeter Polzik, Olav Grøndal, Juliette Tavenier, et al.
Diving and Hyperbaric Medicine|March 19, 2020
Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatmentMorten Hedetoft, Niels V Olsen, Isabel G Smidt-Nielsen, et al.
Diving and Hyperbaric Medicine|June 21, 2025
Core outcome set for research in necrotising soft tissue infection patients: an international, multidisciplinary, modified Delphi consensus studyBridget Devaney, Jonathan Pc Wackett, Nicola Ma, et al.
Pageof 3